NeuroOne Medical Technologies Corporation

NMTC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.39

+$0.09 (+6.92%)

Sep 22, 2026, 1:04 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+6.92%

(1D)

Rating

Updated: Aug 10, 2026

Fundamentals Average

Market Sentiment Bearish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $12.1M

1D Range

1.31 1.39

52W Range

1.30 6.96

Valuation (TTM)

PE -1.35

PB 3.00

EV/EBITDA -1.20

Valuation (NTM)

Forward PE N/A

Forward PEG 0.10

Price Target $5

Cash Flow

FCF Yield -63.3%

SBC Adj. FCF Yield -75.8%

SBC Impact -19.7%

Margins

Gross Margin 55.7%

Operating Margin -76.0%

FCF Margin -71.6%

Growth (CAGR)

Revenue 3Y | 5Y 98.4% | 37.2%

Dil EPS 3Y | 5Y 138.5% | 61.3%

FCF 3Y | 5Y 28.0% | 14.7%

Returns

ROA -115.6%

ROE -126.5%

ROIC -183.4%

Financial Health

Net Cash

$2.05M

Current Ratio 2.84

Interest Coverage 22.76

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode s...

Sector Healthcare

Industry Medical - Devices

Employees 18

IPO Date Mar 14, 2018

Website nmtc1.com

Fiscal Year October - September

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 15, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+259.71%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞